The Intricate Relationship between Type 2 Diabetes Mellitus (T2DM), Insulin Resistance (IR), and Nonalcoholic Fatty Liver Disease (NAFLD)
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Intricate Relationship between Type 2 Diabetes Mellitus (T2DM), Insulin Resistance (IR), and Nonalcoholic Fatty Liver Disease (NAFLD)
Authors
Keywords
-
Journal
Journal of Diabetes Research
Volume 2020, Issue -, Pages 1-16
Publisher
Hindawi Limited
Online
2020-08-05
DOI
10.1155/2020/3920196
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 17β-estradiol ameliorates lipotoxicity-induced hepatic mitochondrial oxidative stress and insulin resistance
- (2020) Bel M. Galmés-Pascual et al. FREE RADICAL BIOLOGY AND MEDICINE
- Sarcopenic Obesity, Insulin Resistance, and Their Implications in Cardiovascular and Metabolic Consequences
- (2020) So-hyeon Hong et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- NAFLD as a driver of chronic kidney disease
- (2020) Christopher D. Byrne et al. JOURNAL OF HEPATOLOGY
- Long-term sucrose solution consumption causes metabolic alterations and affects hepatic oxidative stress in Wistar rats
- (2020) Ellen Mayara Souza Cruz et al. Biology Open
- The Interplay Between Tissue Niche and Macrophage Cellular Metabolism in Obesity
- (2020) Sabine Daemen et al. Frontiers in Immunology
- Insulin resistance, beta-cell function, adipokine profiles and cardiometabolic risk factors among Chinese youth with isolated impaired fasting glucose versus impaired glucose tolerance: the BCAMS study
- (2020) Yu Li et al. BMJ Open Diabetes Research & Care
- Omics‐derived hepatocellular carcinoma risk biomarkers for precision care of chronic liver diseases
- (2020) Naoto Fujiwara et al. HEPATOLOGY RESEARCH
- Epigenetic Regulation of Circadian Rhythm and Its Possible Role in Diabetes Mellitus
- (2020) Michael Hudec et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Gut Microbiota and Predicted Metabolic Pathways in a Sample of Mexican Women Affected by Obesity and Obesity Plus Metabolic Syndrome
- (2019) Alejandra Chávez-Carbajal et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Alcoholic and non-alcoholic steatohepatitis: global perspective and emerging science
- (2019) Gurmehr Brar et al. JOURNAL OF GASTROENTEROLOGY
- Randomized trial comparing effects of weight loss by liraglutide with lifestyle modification in non‐alcoholic fatty liver disease
- (2019) Joan Khoo et al. LIVER INTERNATIONAL
- Adipocyte Death Preferentially Induces Liver Injury and Inflammation Through the Activation of Chemokine (C‐C Motif) Receptor 2‐Positive Macrophages and Lipolysis
- (2019) Seung‐Jin Kim et al. HEPATOLOGY
- Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
- (2019) Peter J. Eddowes et al. GASTROENTEROLOGY
- Systematic review and meta-analysis on the association between phthalates exposure and insulin resistance
- (2019) Bahareh Shoshtari-Yeganeh et al. ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
- Empagliflozin for the Treatment of Nonalcoholic Steatohepatitis in Patients with Type 2 Diabetes Mellitus
- (2019) Lee-Lee Lai et al. DIGESTIVE DISEASES AND SCIENCES
- Pharmacological Treatment for Non-alcoholic Fatty Liver Disease
- (2019) Sven Francque et al. ADVANCES IN THERAPY
- Fructose Promotes Leaky Gut, Endotoxemia and Liver Fibrosis through CYP 2E1‐Mediated Oxidative and Nitrative Stress
- (2019) Young‐Eun Cho et al. HEPATOLOGY
- LBP-20-VK2809, a Novel Liver-Directed Thyroid Receptor Beta Agonist, Significantly Reduces Liver Fat with Both Low and High Doses in Patients with Non-Alcoholic Fatty Liver Disease: A Phase 2 Randomized, Placebo-Controlled Trial
- (2019) Rohit Loomba et al. JOURNAL OF HEPATOLOGY
- Risk stratification of non-alcoholic fatty liver disease across body mass index in a community basis
- (2019) Jee-Fu Huang et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- The association between liver fat and systemic calcified atherosclerosis
- (2019) Bo Kyung Koo et al. JOURNAL OF VASCULAR SURGERY
- The influence of dietary fatty acids on liver fat content and metabolism
- (2019) Leanne Hodson et al. PROCEEDINGS OF THE NUTRITION SOCIETY
- Circadian Clock Genes in the Metabolism of Non-alcoholic Fatty Liver Disease
- (2019) Dongmei Shi et al. Frontiers in Physiology
- Clinically Significant Fibrosis is Associated With Longitudinal Increases in Fibrosis-4 and NAFLD Fibrosis Scores
- (2019) Preya Janubhai Patel et al. Clinical Gastroenterology and Hepatology
- Development and Validation of Hepamet Fibrosis Scoring System A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis
- (2019) Javier Ampuero et al. Clinical Gastroenterology and Hepatology
- A carbohydrate-reduced high-protein diet improves HbA1c and liver fat content in weight stable participants with type 2 diabetes: a randomised controlled trial
- (2019) Mads J. Skytte et al. DIABETOLOGIA
- The Global Epidemiology of NAFLD and NASH in Patients with type 2 diabetes: A Systematic Review and Meta-analysis
- (2019) Zobair M. Younossi et al. JOURNAL OF HEPATOLOGY
- Adiposity May Moderate the Link Between Choline Intake and Non-alcoholic Fatty Liver Disease
- (2019) Mohsen Mazidi et al. JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
- Association of Weight Loss Interventions With Changes in Biomarkers of Nonalcoholic Fatty Liver Disease
- (2019) Dimitrios A. Koutoukidis et al. JAMA Internal Medicine
- Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis
- (2019) Jie Li et al. Lancet Gastroenterology & Hepatology
- The Preventive Effect of Liraglutide on the Lipotoxic Liver Injury via Increasing Autophagy
- (2019) Yini He et al. Annals of Hepatology
- Delayed intervention with a novel SGLT2 inhibitor NGI001 suppresses diet‐induced metabolic dysfunction and nonalcoholic fatty liver disease in mice
- (2019) Hao Chiang et al. BRITISH JOURNAL OF PHARMACOLOGY
- Hypothesis: Role of Reduced Hepatic Insulin Clearance in the Pathogenesis of Type 2 Diabetes
- (2019) Richard N. Bergman et al. DIABETES
- GS-0976 (Firsocostat): an investigational liver-directed acetyl-CoA carboxylase (ACC) inhibitor for the treatment of non-alcoholic steatohepatitis (NASH)
- (2019) Naim Alkhouri et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Circulating microbiota-derived metabolites: a “liquid biopsy?
- (2019) Gemma Aragonès et al. INTERNATIONAL JOURNAL OF OBESITY
- Insulin resistance, but not insulin response, during oral glucose tolerance test (OGTT) is associated to worse histological outcome in obese NAFLD
- (2019) Federica Coccia et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Gut Microbiota-Derived Tryptophan Metabolites Modulate Inflammatory Response in Hepatocytes and Macrophages
- (2019) Smitha Krishnan et al. Cell Reports
- Direct comparison of the specialised blood fibrosis tests FibroMeterV2G and Enhanced Liver Fibrosis score in patients with non-alcoholic fatty liver disease from tertiary care centres
- (2019) Maeva Guillaume et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Non-alcoholic fatty liver disease and cardiovascular disease: assessing the evidence for causality
- (2019) Martijn C. G. J. Brouwers et al. DIABETOLOGIA
- Placebo-controlled randomised trial with liraglutide on magnetic resonance endpoints in individuals with type 2 diabetes: a pre-specified secondary study on ectopic fat accumulation
- (2019) Maurice B. Bizino et al. DIABETOLOGIA
- Liver-Derived Signals Sequentially Reprogram Myeloid Enhancers to Initiate and Maintain Kupffer Cell Identity
- (2019) Mashito Sakai et al. IMMUNITY
- Liver fibrosis by FibroScan ® independently of established cardiovascular risk parameters associates with macrovascular and microvascular complications in patients with type 2 diabetes
- (2019) Rosa Lombardi et al. LIVER INTERNATIONAL
- Low levels of total and high-molecular-weight adiponectin may predict non-alcoholic fatty liver in Korean adults
- (2019) Young-Sang Kim et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Adiponectin and leptin in the diagnosis and therapy of NAFLD
- (2019) Chrysoula Boutari et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology
- (2019) Mohammed Eslam et al. Nature Reviews Gastroenterology & Hepatology
- The influence of Glucose-dependent Insulinotropic Polypeptide (GIP) on human adipose tissue and fat metabolism: Implications for obesity, type 2 diabetes and Non-Alcoholic Fatty Liver Disease (NAFLD)
- (2019) Sravan K. Thondam et al. PEPTIDES
- Leptin/adiponectin ratio correlates with hepatic steatosis but not arterial stiffness in nonalcoholic fatty liver disease in Japanese population
- (2019) Kenichiro Mikami et al. CYTOKINE
- The Novel Adipokine Gremlin 1 Antagonizes Insulin Action and Is Increased in Type 2 Diabetes and NAFLD/NASH
- (2019) Shahram Hedjazifar et al. DIABETES
- 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2020
- (2019) DIABETES CARE
- 2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2019) John B. Buse et al. DIABETES CARE
- Exenatide and dapagliflozin combination improves markers of liver steatosis and fibrosis in patients with type 2 diabetes
- (2019) Amalia Gastaldelli et al. DIABETES OBESITY & METABOLISM
- Could phthalates exposure contribute to the development of metabolic syndrome and liver disease in humans?
- (2019) Nataša Milošević et al. ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
- Trends in pioglitazone use among U.S. adults with type 2 diabetes and suspected nonalcoholic fatty liver disease
- (2019) Phuc Le et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- New drugs for NAFLD: lessons from basic models to the clinic
- (2019) Katharina C. Reimer et al. Hepatology International
- Predictors of Insulin Secretion in Japanese Patients with Histopathologically-confirmed Non-alcoholic Fatty Liver Disease
- (2019) Norio Akuta et al. INTERNAL MEDICINE
- Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease
- (2019) Gordon I. Smith et al. JOURNAL OF CLINICAL INVESTIGATION
- Intestinal microbiome and NAFLD: molecular insights and therapeutic perspectives
- (2019) Haiming Hu et al. JOURNAL OF GASTROENTEROLOGY
- Relationship between non-alcoholic fatty liver disease during pregnancy and abnormal glucose metabolism during and after pregnancy
- (2019) Maryam Sattari et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Influence of lifestyle factors and staple foods from the Mediterranean diet on non-alcoholic fatty liver disease among older individuals with metabolic syndrome features
- (2019) Vanessa Bullón-Vela et al. NUTRITION
- Prevalence of prediabetes and type 2 diabetes in children with obesity and increased transaminases in European German‐speaking countries. Analysis of the APV initiative
- (2019) Florian Koutny et al. Pediatric Obesity
- Pioglitazone improves hepatic mitochondrial function in a mouse model of nonalcoholic steatohepatitis
- (2018) Srilaxmi Kalavalapalli et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- CC chemokine receptor 2 promotes recruitment of myeloid cells associated with insulin resistance in nonalcoholic fatty liver disease
- (2018) Richard Parker et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Impact of Diabetes Mellitus and Insulin on Nonalcoholic Fatty Liver Disease in the Morbidly Obese
- (2018) Cláudia B.M. Strey et al. Annals of Hepatology
- Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease
- (2018) Juan Pablo Arab et al. Annual Review of Pathology-Mechanisms of Disease
- Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease
- (2018) David Højland Ipsen et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Acetyl-CoA Carboxylase Inhibitor GS-0976 for 12 Weeks Reduces Hepatic De Novo Lipogenesis and Steatosis in Patients With Nonalcoholic Steatohepatitis
- (2018) Eric J. Lawitz et al. Clinical Gastroenterology and Hepatology
- The Natural History of Nonalcoholic Fatty Liver Disease—An Evolving View
- (2018) Christina C. Lindenmeyer et al. Clinics in Liver Disease
- Design and rationale of the INSYTE study: A randomised, placebo controlled study to test the efficacy of a synbiotic on liver fat, disease biomarkers and intestinal microbiota in non-alcoholic fatty liver disease
- (2018) Eleonora Scorletti et al. Contemporary Clinical Trials
- DURATION-8 Randomized Controlled Trial 104-Week Results—Once-Weekly Exenatide (ExQW) plus Once-Daily Dapagliflozin (DAPA) vs. ExQW or DAPA Alone
- (2018) SERGE JABBOUR et al. DIABETES
- Saturated Fat Is More Metabolically Harmful for the Human Liver Than Unsaturated Fat or Simple Sugars
- (2018) Panu K. Luukkonen et al. DIABETES CARE
- Specific Hepatic Sphingolipids Relate to Insulin Resistance, Oxidative Stress, and Inflammation in Nonalcoholic Steatohepatitis
- (2018) Maria Apostolopoulou et al. DIABETES CARE
- Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial (E-LIFT Trial)
- (2018) Mohammad Shafi Kuchay et al. DIABETES CARE
- Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study
- (2018) Jan W. Eriksson et al. DIABETOLOGIA
- Histological improvement of non-alcoholic steatohepatitis with a prebiotic: a pilot clinical trial
- (2018) Marc R. Bomhof et al. EUROPEAN JOURNAL OF NUTRITION
- Role of adipokines FGF21, leptin and adiponectin in self-concept of youths with obesity
- (2018) Ge Li et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis
- (2018) Cyrielle Caussy et al. HEPATOLOGY
- New insights into the role and mechanism of c-Jun-N-terminal kinase signaling in the pathobiology of liver diseases
- (2018) Sanda Win et al. HEPATOLOGY
- Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis
- (2018) Oliver Krenkel et al. HEPATOLOGY
- A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis
- (2018) Scott L. Friedman et al. HEPATOLOGY
- The effect of antidiabetic medications on non-alcoholic fatty liver disease (NAFLD)
- (2018) Laura Iogna Prat et al. Hormones-International Journal of Endocrinology and Metabolism
- New Aspects of Lipotoxicity in Nonalcoholic Steatohepatitis
- (2018) Nahum Mendez-Sanchez et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Hepatic IRS1 and ß-catenin expression is associated with histological progression and overt diabetes emergence in NAFLD patients
- (2018) Kenichiro Enooku et al. JOURNAL OF GASTROENTEROLOGY
- To die or not to die: death signaling in nonalcoholic fatty liver disease
- (2018) Yuko Akazawa et al. JOURNAL OF GASTROENTEROLOGY
- MGL-3196, a selective thyroid hormone receptor-beta agonist significantly decreases hepatic fat in NASH patients at 12 weeks, the primary endpoint in a 36 week serial liver biopsy study
- (2018) S. Harrison et al. JOURNAL OF HEPATOLOGY
- The role of Kupffer cells in hepatic iron and lipid metabolism
- (2018) Charlotte L. Scott et al. JOURNAL OF HEPATOLOGY
- Lipotoxicity and the gut-liver axis in NASH pathogenesis
- (2018) Fabio Marra et al. JOURNAL OF HEPATOLOGY
- Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policies
- (2018) Laura Pimpin et al. JOURNAL OF HEPATOLOGY
- Diabetes impacts prediction of cirrhosis and prognosis by non-invasive fibrosis models in non-alcoholic fatty liver disease
- (2018) Luis C. Bertot et al. LIVER INTERNATIONAL
- Mechanisms of NAFLD development and therapeutic strategies
- (2018) Scott L. Friedman et al. NATURE MEDICINE
- Animal models of obesity and diabetes mellitus
- (2018) Maximilian Kleinert et al. Nature Reviews Endocrinology
- Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease
- (2018) Mario Masarone et al. Oxidative Medicine and Cellular Longevity
- Distinct macrophage populations direct inflammatory versus physiological changes in adipose tissue
- (2018) David A. Hill et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MR Spectroscopy–derived Proton Density Fat Fraction Is Superior to Controlled Attenuation Parameter for Detecting and Grading Hepatic Steatosis
- (2018) Jurgen Henk Runge et al. RADIOLOGY
- Nonalcoholic Fatty Liver Disease in Children
- (2018) Jake Mann et al. SEMINARS IN LIVER DISEASE
- Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?
- (2018) Ivana Mikolasevic et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Mediterranean diet and nonalcoholic fatty liver disease
- (2018) Caterina Anania et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Abdominal subcutaneous and visceral adipocyte size, lipolysis and inflammation relate to insulin resistance in male obese humans
- (2018) K. Verboven et al. Scientific Reports
- Long-term effects of increased protein intake after weight loss on intrahepatic lipid content and implications for insulin sensitivity - a PREVIEW study
- (2018) Mathijs Drummen et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Suppression of NF-κB activation by PDLIM2 restrains hepatic lipogenesis and inflammation in high fat diet induced mice
- (2018) Ya-Rong Hao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Remission of Human Type 2 Diabetes Requires Decrease in Liver and Pancreas Fat Content but Is Dependent upon Capacity for β Cell Recovery
- (2018) Roy Taylor et al. Cell Metabolism
- Safety and Efficacy of Exenatide Once Weekly Plus Dapagliflozin Once Daily Versus Exenatide or Dapagliflozin Alone in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy: 52-Week Results of the DURATION-8 Randomized Controlled Trial
- (2018) Serge A. Jabbour et al. DIABETES CARE
- Evaluation of the effects of dapagliflozin, an SGLT2 inhibitor, on hepatic steatosis and fibrosis by transient elastography in patients with type 2 diabetes and non-alcoholic fatty liver disease
- (2018) Masanori Shimizu et al. DIABETES OBESITY & METABOLISM
- Effect of luseogliflozin on hepatic fat content in type 2 diabetes patients with non-alcoholic fatty liver disease: A prospective, single-arm trial (LEAD trial)
- (2018) Yoshio Sumida et al. HEPATOLOGY RESEARCH
- ISPAD Clinical Practice Consensus Guidelines 2018 Definition, epidemiology and classification of diabetes in children and adolescents
- (2018) Elizabeth J. Mayer-Davis et al. PEDIATRIC DIABETES
- Intracellular lipids are an independent cause of liver injury and chronic kidney disease in non alcoholic fatty liver disease-like context
- (2018) Laure Monteillet et al. Molecular Metabolism
- Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease
- (2018) Fasiha Kanwal et al. GASTROENTEROLOGY
- Liraglutide, sitagliptin and insulin glargine added to metformin: the effect on body weight and intrahepatic lipid in patients with type 2 diabetes mellitus and NAFLD
- (2018) Jinhua Yan et al. HEPATOLOGY
- Impact of SGLT2 inhibitor to histological features and glucose metabolism of non-alcoholic fatty liver disease complicated by diabetes mellitus
- (2018) Norio Akuta et al. HEPATOLOGY RESEARCH
- Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial
- (2018) Arun Sanyal et al. LANCET
- The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
- (2018) Konstantin Kazankov et al. Nature Reviews Gastroenterology & Hepatology
- Glutamine Metabolism in Macrophages: A Novel Target for Obesity/Type 2 Diabetes
- (2018) Wenkai Ren et al. Advances in Nutrition
- Leptin trajectories from birth to mid-childhood and cardio-metabolic health in early adolescence
- (2018) Ling-Jun Li et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Genetics of Diabetes Insipidus
- (2017) Marie Helene Schernthaner-Reiter et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Gut microbiota functions: metabolism of nutrients and other food components
- (2017) Ian Rowland et al. EUROPEAN JOURNAL OF NUTRITION
- Fatty acids promote fatty liver disease via the dysregulation of 3-mercaptopyruvate sulfurtransferase/hydrogen sulfide pathway
- (2017) Meng Li et al. GUT
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Randomized Controlled Trial of a MUFA or Fiber-Rich Diet on Hepatic Fat in Prediabetes
- (2017) Isabel Errazuriz et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Distinct but complementary contributions of PPAR isotypes to energy homeostasis
- (2017) Vanessa Dubois et al. JOURNAL OF CLINICAL INVESTIGATION
- Response to: Comment to “EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease”
- (2017) Giulio Marchesini et al. JOURNAL OF HEPATOLOGY
- Treatment of NAFLD with diet, physical activity and exercise
- (2017) Manuel Romero-Gómez et al. JOURNAL OF HEPATOLOGY
- Gamma-glutamyltransferase, fatty liver index and hepatic insulin resistance are associated with incident hypertension in two longitudinal studies
- (2017) Fabrice Bonnet et al. JOURNAL OF HYPERTENSION
- Oral Supplementation of Glutamine Attenuates the Progression of Nonalcoholic Steatohepatitis in C57BL/6J Mice
- (2017) Cathrin Sellmann et al. JOURNAL OF NUTRITION
- Dual PPARα/γ agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH models
- (2017) Mukul R. Jain et al. LIVER INTERNATIONAL
- The epidemiology of non-alcoholic fatty liver disease
- (2017) Stefano Bellentani LIVER INTERNATIONAL
- The Role of Tissue Macrophage-Mediated Inflammation on NAFLD Pathogenesis and Its Clinical Implications
- (2017) Anna Alisi et al. MEDIATORS OF INFLAMMATION
- Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus
- (2017) Wenjie Dai et al. MEDICINE
- Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
- (2017) Zobair Younossi et al. Nature Reviews Gastroenterology & Hepatology
- Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments
- (2017) Hironori Kitade et al. Nutrients
- Absence of Carbohydrate Response Element Binding Protein in Adipocytes Causes Systemic Insulin Resistance and Impairs Glucose Transport
- (2017) Archana Vijayakumar et al. Cell Reports
- Metabolically Activated Adipose Tissue Macrophages Perform Detrimental and Beneficial Functions during Diet-Induced Obesity
- (2017) Brittney R. Coats et al. Cell Reports
- NLRP3 Inflammasome Expression and Signaling in Human Diabetic Wounds and in High Glucose Induced Macrophages
- (2017) Xiaotian Zhang et al. Journal of Diabetes Research
- JNK at the crossroad of obesity, insulin resistance, and cell stress response
- (2017) Giovanni Solinas et al. Molecular Metabolism
- Obesity
- (2017) Pedro González-Muniesa et al. Nature Reviews Disease Primers
- Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus
- (2016) Kenneth Cusi et al. ANNALS OF INTERNAL MEDICINE
- Pathogenesis of nonalcoholic steatohepatitis
- (2016) Wensheng Liu et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Increased prevalence and risk of non-alcoholic fatty liver disease in overweight and obese patients with Type 2 diabetes in South China
- (2016) M. Yi et al. DIABETIC MEDICINE
- Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
- (2016) Vlad Ratziu et al. GASTROENTEROLOGY
- Pathogenesis of Nonalcoholic Steatohepatitis
- (2016) Mariana Verdelho Machado et al. GASTROENTEROLOGY
- Effect of sodium glucose cotransporter 2 inhibitor on liver function tests in Japanese patients with non-alcoholic fatty liver disease and type 2 diabetes mellitus
- (2016) Yuya Seko et al. HEPATOLOGY RESEARCH
- Effect of liraglutide therapy on liver fat content in patients with inadequately controlled type 2 diabetes. The Lira-NAFLD study
- (2016) Jean-Michel Petit et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis
- (2016) Stefano Ballestri et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Not routine screening, but vigilance for chronic liver disease in patients with type 2 diabetes
- (2016) Vincent Wai-Sun Wong et al. JOURNAL OF HEPATOLOGY
- Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis
- (2016) Matthew J. Armstrong et al. JOURNAL OF HEPATOLOGY
- How to diagnose NAFLD in 2016
- (2016) E. Bugianesi et al. JOURNAL OF HEPATOLOGY
- Liver innate immune cells and insulin resistance: the multiple facets of Kupffer cells
- (2016) J. Jager et al. JOURNAL OF INTERNAL MEDICINE
- Lipid signaling and lipotoxicity in metaflammation: indications for metabolic disease pathogenesis and treatment
- (2016) Meric Erikci Ertunc et al. JOURNAL OF LIPID RESEARCH
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes?
- (2016) Luca Valenti et al. LIVER INTERNATIONAL
- Non-alcoholic fatty liver disease and diabetes
- (2016) Jonathan M. Hazlehurst et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The Reactive Oxygen Species in Macrophage Polarization: Reflecting Its Dual Role in Progression and Treatment of Human Diseases
- (2016) Hor-Yue Tan et al. Oxidative Medicine and Cellular Longevity
- Local proliferation initiates macrophage accumulation in adipose tissue during obesity
- (2016) C Zheng et al. Cell Death & Disease
- Glutamine Modulates Macrophage Lipotoxicity
- (2016) Li He et al. Nutrients
- Pioglitazone use and risk of bladder cancer: population based cohort study
- (2016) Marco Tuccori et al. BMJ-British Medical Journal
- Pioglitazone use and risk of bladder cancer: population based cohort study
- (2016) Marco Tuccori et al. BMJ-British Medical Journal
- The Burden of NAFLD and Its Characteristics in a Nationwide Population with Type 2 Diabetes
- (2016) Gabriele Forlani et al. Journal of Diabetes Research
- Exenatide once weekly plus dapagliflozin once daily versus exenatide or dapagliflozin alone in patients with type 2 diabetes inadequately controlled with metformin monotherapy (DURATION-8): a 28 week, multicentre, double-blind, phase 3, randomised controlled trial
- (2016) Juan P Frías et al. Lancet Diabetes & Endocrinology
- Metabolic reprogramming through fatty acid transport protein 1 (FATP1) regulates macrophage inflammatory potential and adipose inflammation
- (2016) Amy R. Johnson et al. Molecular Metabolism
- Targeted Induction of Ceramide Degradation Leads to Improved Systemic Metabolism and Reduced Hepatic Steatosis
- (2015) Jonathan Y. Xia et al. Cell Metabolism
- Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study
- (2015) Raymond Kwok et al. GUT
- Liver inflammation abrogates immunological tolerance induced by Kupffer cells
- (2015) Felix Heymann et al. HEPATOLOGY
- Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009
- (2015) Zobair M. Younossi et al. HEPATOLOGY
- Polyphenols and non-alcoholic fatty liver disease: impact and mechanisms
- (2015) I. Rodriguez-Ramiro et al. PROCEEDINGS OF THE NUTRITION SOCIETY
- Long-Term Treatment with n-3 Polyunsaturated Fatty Acids as a Monotherapy in Children with Nonalcoholic Fatty Liver Disease
- (2015) Mehmet Boyraz et al. Journal of Clinical Research in Pediatric Endocrinology
- Local Proliferation of Macrophages Contributes to Obesity-Associated Adipose Tissue Inflammation
- (2014) Shinya U. Amano et al. Cell Metabolism
- Pilot study of liraglutide effects in non-alcoholic steatohepatitis and non-alcoholic fatty liver disease with glucose intolerance in Japanese patients (LEAN-J)
- (2014) Yuichiro Eguchi et al. HEPATOLOGY RESEARCH
- The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes
- (2014) Rachel J. Perry et al. NATURE
- Liver fatty acid-binding protein as a diagnostic marker for non-alcoholic fatty liver disease
- (2014) Erdem Akbal et al. WIENER KLINISCHE WOCHENSCHRIFT
- Renal sodium glucose cotransporter 2 inhibitors as a novel therapeutic approach to treatment of type 2 diabetes: Clinical data and mechanism of action
- (2014) Yoshihito Fujita et al. Journal of Diabetes Investigation
- Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 Diabetes
- (2013) Andreas L. Birkenfeld et al. HEPATOLOGY
- Resolution of Fatty Liver and Risk of Incident Diabetes
- (2013) Ki-Chul Sung et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease
- (2013) Yuki Kawano et al. JOURNAL OF GASTROENTEROLOGY
- Performance of Biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in Patients with Severe Obesity: Meta Analysis of Individual Patient Data
- (2012) Thierry Poynard et al. PLoS One
- Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents
- (2011) Joel E. Lavine JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pro-Inflammatory CD11c+CD206+ Adipose Tissue Macrophages Are Associated With Insulin Resistance in Human Obesity
- (2010) J. M. Wentworth et al. DIABETES
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enhancement in liver SREBP-1c/PPAR-α ratio and steatosis in obese patients: Correlations with insulin resistance and n-3 long-chain polyunsaturated fatty acid depletion
- (2009) Paulina Pettinelli et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Metformin and Insulin Suppress Hepatic Gluconeogenesis through Phosphorylation of CREB Binding Protein
- (2009) Ling He et al. CELL
- Depletion of Liver Kupffer Cells Prevents the Development of Diet-Induced Hepatic Steatosis and Insulin Resistance
- (2009) W. Huang et al. DIABETES
- Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: Results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial
- (2009) Vlad Ratziu et al. HEPATOLOGY
- Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis
- (2008) R. LOOMBA et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial
- (2008) Vlad Ratziu et al. GASTROENTEROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started